Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Mosaic TX logo — Resolving cancer's complexity through the power of targeted...

Mosaic TX

Resolving cancer's complexity through the power of targeted drug combinations

Founded 2020 United Kingdom United Kingdom 15 employees Series A Total: $28.52M Biotechnology, Health and Wellness

General Information

Company Name Mosaic TX
Founded Year 2020
Location United Kingdom United Kingdom
Employees 15
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Business Model B2B, Platform
Revenue Model Licensing, Performance Based, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Mosaic TX. To contact Mosaic TX, visit mosaic-tx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Mosaic TX compare?

A PDF of Mosaic TX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Mosaic TX soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Mosaic TX

Mosaic TX, established in 2020 and headquartered in the United Kingdom, is forging a path in the Biotechnology and Health and Wellness industries. Their mission, encapsulated in the slogan "Resolving cancer's complexity through the power of targeted drug combinations," highlights their focus on addressing critical unmet needs in oncology through innovative therapies.

Their strength lies in a unique dual technology platform, honed over two decades, that focuses on pioneering combination therapies for various cancer types. This platform, developed alongside the prestigious Wellcome Sanger Institute and Netherlands Cancer Institute, drives their precision medicine initiatives, particularly for patient groups lacking targeted treatment options.

Recently, Mosaic TX secured a $28.00M Series A investment as of April 1, 2023, led by investors Cambridge Innovation Capital and Syncona Investment Management. This funding underscores strong investor confidence in their novel approach to cancer treatment and promises to propel their growth within this competitive sector.

Business keywords: oncology therapeutics, precision medicines, targeted drug combinations, cancer drug discovery, computational medicine, experimental medicine, tumor agnostic therapies, genomics, organoids, machine learning in drug development, disease biology pathways, combination therapies, dual technology platform, precision medicine development, Wellcome Sanger Institute collaboration

Services & Products

Discovery and development of targeted combination therapies
Biomarker-defined treatment development
Experimental and computational biology platforms
CRISPR and drug screening
Partnerships with research institutes and investors

Target Customers

Cancer patients in need of precision medicine Healthcare providers looking for advanced cancer treatment options Pharmaceutical companies interested in licensing novel cancer therapies Investors in biotech and pharmaceutical innovations Research collaborators in oncology and genomics

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $28.00M 2
Cambridge Innovation Capital Syncona Investment Management
Cambridge Innovation Capital, Syncona Investment Management
01 Apr 2023
Grant £520.00K 1
Innovate UK
Innovate UK
01 Nov 2020
Spinout Undisclosed 1
Wellcome Trust
Wellcome Trust
01 Jan 2020

Mosaic TX Alternatives & Competitors

View All Alternatives
Mosaic TX vs
Prelude Therapeutics
Prelude Therapeutics United States

Precision Oncology, Redefined.

Post-IPO Equity
126 employees
Biopharma, Biotechnology
Mosaic TX vs
Macomics
Macomics United Kingdom

Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the...

Series A
24 employees
Biotechnology, Health and Wellness
Mosaic TX vs
Epitopea
Epitopea Canada

Exploiting a new class of tumour specific antigens for cancer therapy

Seed
50 employees
Biotechnology, Health and Wellness
Compare Mosaic TX vs Epitopea
Also compare with: Mosaic TX vs Relay Therapeutics Relay Therapeutics View all alternatives

FAQ About Mosaic TX

Resolving cancer's complexity through the power of targeted drug combinations
Mosaic TX was founded in 2020.
Mosaic TX is headquartered in United Kingdom.
Mosaic TX operates in Biotechnology and Health and Wellness. Its work centres on oncology therapeutics, precision medicines, targeted drug combinations and cancer drug discovery. Its customers include Cancer patients in need of precision medicine, Healthcare providers looking for advanced cancer treatment options and Pharmaceutical companies interested in licensing novel cancer therapies.
Mosaic TX has a B2B and Platform business model. Its revenue comes from Licensing, Performance Based and Product Sales.
Mosaic TX has approximately 15 employees.
Mosaic TX has completed 3 funding rounds, raising a total of $28.52M. The latest funding stage is Series A.
Mosaic TX offers: Discovery and development of targeted combination therapies, Biomarker-defined treatment development, Experimental and computational biology platforms, CRISPR and drug screening, Partnerships with research institutes and investors.
Top alternatives and competitors to Mosaic TX include Prelude Therapeutics, Macomics, Epitopea, KSQ Therapeutics, Inc., Arcus Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mosaic TX and Prelude Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mosaic TX, https://bouncewatch.com/company/mosaic-tx, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes